Stress cardiomyopathy is an acute reversible heart failure syndrome initially believed to
represent a benign condition due to its self-limiting clinical course, but now recognized to be …

This is the first part of a scientific statement from the Heart Failure Association (HFA) of the
European Society of Cardiology focused upon the pathophysiology of Takotsubo syndrome …

The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the
diagnostic workup, outcome, and management. The recommendations are based on …

In the clinical setting, Takotsubo syndrome (TTS) is one of the most important diseases that
must be accurately differentiated from acute coronary syndrome (ACS) to enable appropriate …

Background and objectives: Currently, there are no specific diagnostic electrocardiogram
(ECG) signs for Takotsubo syndrome (TTS) to differentiate it from acute coronary syndromes …

Aims We aimed to evaluate the frequency, clinical features, and prognostic implications of
cardiac arrest (CA) in takotsubo syndrome (TTS). Methods and results We reviewed the …

First described in Japan over 2 decades ago, takotsubo cardiomyopathy (TTC) has emerged
as a unique cardiomyopathy with world-wide recognition, mimicking acute coronary …

Although prognosis of Takotsubo cardiomyopathy (TTC) is generally thought to be favorable,
the initial presentation can be accompanied by various complications, including life …

Aim Stress‐induced cardiomyopathy (SIC), also known as takotsubo cardiomyopathy, is an
acute cardiac syndrome with substantial morbidity and mortality. The unique hallmark of SIC …

Background and purpose Previous studies revealed that Takotsubo cardiomyopathy (TTC),
a transient disorder of ventricular dysfunction affecting predominantly postmenopausal …